Clinical research studies

We currently support a number of clinical research studies, including:

  • CHERRY: Feasibility study on the effects of L-citrulline on cardiovascular function in hypertensive pregnant women. Women with hypertension identified before 16 weeks gestation will be invited to participate.
    Contact: Heather Glossop /Catherine Chmiel ext. 16980/16968
  • HOLDS: Nuliparous and over 16 years of age. 37-42 weeks gestation, singleton pregnancy. Confirmed delay in labour. Normal pregnancy.
    Contact: Linda Peacock /Sam Ratcliffe ext. 16958/16980
  • BOOST: Supplementation with cereal bars or tablets in young pregnant women. Aged <19 years at recruitment to the study. Singleton pregnancy.
    Contact: Sam Ratcliffe ext. 16980
  • MAViS: Women with Vascular Disease. >10 weeks gestation.
    Contact: Catherine Chmiel and Heather Glossop ext. 16980/16968
  • TEMPO: Pregancy with better eating and activity trial.
    Christine Hughes ext. 11937
  • BUMP: Blood Pressure Monitoring in Pregnancy to improve the detection and monitoring of hypertension. 16-24 weeks gestation with 1 risk factor for hypertension OR <37 weeks with existing hypertension.
    Contact: Kim Farrant ext. 16958
  • PAGE: Detecting problems in pregnancy, possibly requiring a CVS or Amniocentesis. Any gestation.
    Contact: Sue Thornber ext. 16980
  • IONA TWINS: Women undergoing CVS or Amniocentesis. Any gestation.
    Contact: Linda Peacock ext. 16958
  • GOT-IT: Women with Retained Placenta, >14 weeks gestation.
    Contact: Linda Peacock ext. 16958
  • C-STITCH: Preterm Birth Study. Women indicated for cervical cerclage: suture is randomised: monofilment vs braided.
    Sue Thornber ext. 16980
  • VELOCITY: Evaluation of fetal growth in pregnancies complicated by diabetes. Type 1 and 2 diabetes.
    Contact: Heather Glossop ext. 16980
  • INVEST: Mother presents with increased fetal movements to antenatal services (>28weeks).
    Contact: Liz Ward/Kim Farrant ext. 16958
  • TOMMYS: All pregnant women.
    Jessica Morecroft /Christine Hughes ext. 16988
  • RAINBOW: To explore the experiences and outcomes of women who attend the Rainbow clinic.
    Contact: Louise Stephens/ Suzanne Thomas/ Christine Hughes ext. 11937
  • PARROT: PlGF as a diagnostic test for pre-eclampsia. Women between 20-36+6 weeks gestation who have suspected pre-eclampsia, who require PE bloods.
    Contact: Sarah Lee ext. 65022
  • STOPPIT-2: Twin Pregnancies, 18+0 –20+6 gestation.
    Contact: Sue Thornber ext. 16980
  • PARENTS-2: Involving parents in the perinatal mortality meeting. Parents who have suffered a stillbirth or a neonatal death.
    Contact: Kim Farrant ext. 16958
  • FEMINA 3: Women attending 28 weeks onward with reduced fetal movement.
    Contact: – Louise Stephens/Kim Farrant ext. 16965/16958
  • PHOENIX: Pre-eclampsia, 34 – 36+6 weeks gestation.
    Contact: Sarah Lee ext. 65022
  • PEACOCK: Pre-eclampsia (34-36+6 weeks gestation) Can a Placental Growth Factor (PLGF) blood test (plus clinical factors), be used to help plan the management of women with pre-eclampsia in the future. 
    Contact: Sarah Lee ext. 65022
  • PHOEBE: Pre-eclampsia (34-36+6 weeks gestation). Why women with PE might have changes in heart function postnatally. 
    Contact: Sarah Lee ext. 65022
  • NUPS 2: New Ultrasound Parameters for predicting birth weight 2.
    Contact: Sarah Lee or Dr Zoe Thurlwell ext. 65022
  • REMIT-2: Women after 36 weeks gestation attending with reduced fetal movements. 
    Contact: Sam Ratcliffe/Linda Peacock ext. 16980/16958

For more information about these studies and other research in the area of maternal and fetal health please contact Research Midwife Coordinator or 0161 701 6968